Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,373 | -74,013 | -58,125 | -57,280 | -24,690 |
| Depreciation Amortization | -582 | -1,450 | -87 | 1,247 | 821 |
| Accounts receivable | -45 | -803 | -36 | -7 | -80 |
| Other Working Capital | -18,838 | 43,219 | -3,047 | 5,989 | 164 |
| Other Operating Activity | 16,613 | 10,746 | 6,468 | 2,670 | 2,307 |
| Operating Cash Flow | $-109,225 | $-22,301 | $-54,827 | $-47,381 | $-21,478 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -30,498 | -82,746 | -36,483 | 45,735 | -91,657 |
| PPE Investments | -18 | -73 | -17 | -717 | -20 |
| Investing Cash Flow | $-30,516 | $-82,819 | $-36,500 | $45,018 | $-91,677 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 142,604 | 110,813 | 87,923 | 123 | 75,593 |
| Financing Cash Flow | $142,604 | $110,813 | $87,923 | $123 | $75,593 |
| Beginning Cash Position | 15,850 | 10,157 | 13,561 | 15,801 | 52,663 |
| End Cash Position | 18,713 | 15,850 | 10,157 | 13,561 | 15,101 |
| Net Cash Flow | $2,863 | $5,693 | $-3,404 | $-2,240 | $-37,562 |
| Free Cash Flow | |||||
| Operating Cash Flow | -109,225 | -22,301 | -54,827 | -47,381 | -21,478 |
| Capital Expenditure | -18 | -73 | -58 | -717 | -20 |
| Free Cash Flow | -109,243 | -22,374 | -54,885 | -48,098 | -21,498 |